BIOMAT Database Logo BIOMAT Database Logo

Refractory oedema in congestive heart failure: a contributory role of loop diuretics. 1995

O M Jolobe

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

O M Jolobe
Refractory oedema in congestive heart failure: a contributory role of loop diuretics?
February 1995, Journal of internal medicine,
O M Jolobe
Pharmacokinetics of loop diuretics in congestive heart failure.
August 1994, British heart journal,
O M Jolobe
Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics.
January 2003, Congestive heart failure (Greenwich, Conn.),
O M Jolobe
Thiazides with loop diuretics for severe congestive heart failure.
April 1990, Lancet (London, England),
O M Jolobe
Management of congestive heart failure; role of diuretics.
June 1948, The Mississippi doctor,
O M Jolobe
Diuretics in congestive heart failure.
February 1989, Cardiology clinics,
O M Jolobe
Diuretics in congestive heart failure.
February 1960, The Journal of the Medical Society of New Jersey,
O M Jolobe
Role of diuretics and ultrafiltration in congestive heart failure.
July 2013, Pharmaceuticals (Basel, Switzerland),
O M Jolobe
Ibopamine in congestive heart failure refractory to digitalis, diuretics, and captopril.
January 1986, Journal of clinical pharmacology,
O M Jolobe
Pharmacoeconomic comparison of loop diuretics in the treatment of congestive heart failure.
January 1996, Medical interface,
Copied contents to your clipboard!